We are excited to partner with Dr. Yue Liu and team to potentially discover and advance novel program candidates for autoimmune indications,” said Dr. Ken Song, Chairman, President and CEO of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback